Insulin Caps Lowered Costs But Didn’t Improve Access, Study Finds

State caps on insulin costs lowered privately insured patients’ out-of-pocket spending, but they didn’t appear to increase insulin use, according to a new Annals of Internal Medicine study.

Why it matters: The research suggests increasingly popular insulin caps alone aren’t enough to improve insulin uptake among patients with diabetes in commercial insurance.

  • At least half of states in recent years have limited monthly insulin costs in the commercial market, and leading insulin manufacturers have followed suit as the Biden administration pushes a national cap for privately insured patients.

What they found: State insulin caps, which range from $25 to $100 for a month’s supply, were associated with 17.4% relative decrease in consumer out-of-pocket costs, researchers from Harvard Medical School and Harvard Pilgrim Health Care Institute found.

  • The savings were over twice as large (40%) among patients using health savings accounts, while patients in states with caps between $25 and $30 were most likely to see a drop in costs.
  • However, insulin use remained constant for nearly all populations, though it increased for lower-income patients with HSAs in states with $25-$30 caps.

The intrigue: Previous studies found Medicare enrollees’ prescription fills rose after Medicare implemented a new $35 cap on monthly insulin costs.

  • Researchers said those with private insurance are on average healthier and less likely to need insulin, and they might be less affected by caps because they have more resources to afford the medication.

What they’re saying: “Other policies might be needed to improve access to affordable insulin among commercially insured patients with diabetes who have cost-related underuse,” the authors wrote.

 

Source Link

Recommended Articles

State PBM laws Face ERISA Preemption Challenges in Court

States seeking to limit the power of pharmacy benefit managers are running into legal roadblocks. Every state, as well as the federal government, has enacted PBM legislation over the last decade to rein in an industry accused of anticompetitive business practices. Those efforts have seen mixed results as agencies struggle to enforce requirements and courts ...

Read More

Employer Health Cost Crunch Is Worse Than Projected

There’s new evidence that double-digit health cost increases were hitting employers well before the forecasts of big spikes for 2027 — forcing big changes in workplace coverage for millions of Americans. Why it matters: The findings offer a higher-resolution view of how much health spending is putting a drag on the labor market and increasing ...

Read More

HHS Finalizes Changes To HIPAA Privacy Rule

HHS' Office for Civil Rights finalized a HIPAA privacy rule change cutting the protected health information request response window to 15 calendar days. The final regulation clarifies individuals can retrieve electronic PHI through health apps when entities can support that format.

Read More

Sutter Health-Allina Health Deal Clears Key Hurdle

Sutter Health and Allina Health have achieved a milestone in their plan to merge. The health systems agreed to invest $2.15 billion as part of a 10-year oversight arrangement that Minnesota Attorney General Keith Ellison (D) announced Monday. The deal has been under state review for months. Under terms of the agreement, Sacramento, California-based Sutter ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square